Matinas Biopharma Holdings I

Penny Stocks Biotech Stocks Healthcare Stocks

$2.53

+0.13 (+5.42%)

As of Sep 28, 10:46 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +1,454.5% upside

Low Target $22.47

Average Target $39.33

High Target $48.65

Current Price $2.53

Current
$2.53

Target
$39.33

$22.47 $39.33 avg $48.65

Scenario Analysis

Bear Case

$22.47

788.1%

Low target

Base Case

$39.33

+1,454.5%

Avg target

Bull Case

$48.65

+1,822.9%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.02

25.2% from high

52-Week Low

$0.15

+1,581.1% from low

Target vs 52W High

$39.33

+1,847.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%